跳至主要内容
临床试验/IRCT20220418054581N1
IRCT20220418054581N1招募中3 期

The effect of L-carnitine supplementation on mortality and serum levels of C-reactive protein in obese patients with coronavirus (nCov-2019) with acute respiratory failure admitted to intensive care unit

Artesh University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients over 18 years
  • Diagnosis of clinical and laboratory signs of severe Covid-19
  • Body mass index above 29.9 kg per square meter based on the weight in the file
  • Completion of the informed consent form by the patient or his / her legal guardian
  • Severe COVID-19 patients who are admitted to the medical ICU (MICU) and will require respiratory support
  • Patients with normal GI function who receive enteral feeding

排除标准

  • Receive any L-carnitine supplement in the last 6 months
  • Participate in any other research project
  • History of liver and kidney disease
  • Pregnancy and lactation
  • Any allergy to L-carnitine
  • Patients who stayed in the ICU for < 72 hours
  • Patients who receive parenteral nutritional support
  • Patients treated with different drug regimens from the routine ICU protocol
  • Patients will be ongoing treatment with cisplatin, phenobarbital, phenytoin, pivalic acid, valproic acid, ifosfamide, and levetiracetam
  • Any gastrointestinal disorders that lead to stopping enteral feeding for more than 48 hours

研究者

发起方
Artesh University of Medical Sciences

相似试验